Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves

Local and Regional Anesthesia

Volumn 5, Issue 1, 2012, Pages 47-53

  Correa Illanes, Gerardo ^a   Roa, Ricardo ^b   Piñeros, José Luis ^b   Calderón, Wilfredo ^c  

^a Rehabilitation Department   (Chile)

^b HOSPITAL DEL TRABAJADOR   (Chile)

^c HOSPITAL DEL SALVADOR   (Chile)

Author keywords

5 lidocaine medicated plaster; Chronic post surgical pain; Chronic post traumatic pain; Neuropathic pain; Peripheral nerve injury

Indexed keywords

ANALGESIC AGENT; BUPRENORPHINE; GABAPENTIN; LIDOCAINE; PARACETAMOL; PREGABALIN; TRAMADOL;

ADULT; AGED; ARM INJURY; ARTICLE; CHRONIC LOCALIZED NEUROPATHIC PAIN; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE DURATION; DOULEUR NEUROPATHIQUE QUESTIONNAIRE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LEG INJURY; MALE; MEDICAL DEVICE; MEDICATED PLASTER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT DURATION;

EID: 84930474761     PISSN: None     EISSN: 11787112     Source Type: Journal    
DOI: 10.2147/LRA.S31868     Document Type: Article

References (29)

1. Treede R, Jensen T, Campbell JN, etal. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630-1635.
2. Ciaramitaro P, Mondelli M, Logullo F, etal. Traumatic peripheral nerve injuries: epidemiological findings, neuropathic pain and quality of life in 158 patients. J Periph Nerv Sys. 2010;15:120-127.
3. Delorme C, Navez ML, Legout V, Deleens R, Moyse D. Treatment of neuropathic pain with 5% lidocaine-medicated plaster: Five years of clinical experience. Pain Res Manag. 2011;16:259-263.
4. Hernández N, Hernández J, Moreno C. Use of lidocaine patches in the relief of localised neuropathic pain. Rev Iberoamericana del Dolor. 2009;1(4):13-28.
5. Finnerup NB, Sindrup SH, Jensen TS. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol. 2007;21:129-136.
6. Schüning J, Scherens A, Haussleiter IS, etal. Sensory changes and loss of intraepidermal nerve fibers in painful unilateral nerve injury. Clin J Pain. 2009;25:683-690.
7. Dworkin R, O'Connor A, Audette J, etal. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(Suppl 3):S3-S14.
8. Finnerup N, Sindrup S, Jensen T. Recent advances in pharmacological treatment of neuropathic pain. F1000 Med Rep. 2010;2:52.
9. Acevedo JC, Amaya A, de León-Casasola O, etal. Guías para el diagnóstico y el manejo del dolor neuropático:consenso de un grupo de expertos latinoamericanos. Rev Iberoamericana del Dolor. 2008;2:15-46.
10. Asociación Chilena para Estudio del Dolor (AChED). Guías para la Definición y el Manejo del Dolor Neuropático Localizado. Consenso Chileno. El Dolor. Octubre 2011. Edición especial.
11. Mick G, Baron R, Finnerup NB, etal. What is localized neuropathic pain? A first proposal to characterize and define a widely used term. Pain Management. 2012;2(1):71-77.
12. Haanpää M. Mechanism-based treatment of herpes zoster and postherpetic neuralgia. Europ J Pain. 2007;11(S1):S38.
13. Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26(7):1607-1619.
14. Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurology. 2005;252(6):677-686.
15. Katz NP, Gammaitoni A, Davis M, etal. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial: the Lidoderm Patch Study Group. Pain Med. 2002;3(4):324-332.
16. Galer B, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18(5):297-301.
17. Bouhassira D, Attal N, Alchaar H, etal. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36.
18. Perez C, Galvez R, Huelbes S, etal. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual Life Outcomes. 2007;5:66.
19. Shafighi M, Gurunluoglu R, Ninkovic M, Mallouhi A, Bodner G. Ultrasonography for depiction of brachial plexus injury. J Ultrasound Med. 2003;22(6):631-634.
20. Provost N, Bonaldi VM, Saravin L. Amputation stump neuroma: Ultrasound features. J Clin Ultrasound. 1997;25(2):85-89.
21. Hans G, Joukes E, Verhulst J, Vercauteren M. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases. Curr Med Res Opin. 2009; 25(11):2737-2743.
22. Taylor KS, Anastakis DJ, Davis KD. Chronic pain and sensorimotor deficits following peripheral nerve injury. Pain. 2010;151:582-591.
23. Landerholm AH, Ekblom AG, Hansson PT. Somatosensory function in patients with and without pain after traumatic peripheral nerve injury. Eur J Pain. 2010;14:847-853.
24. de Leon-Casasola OA. Multimodal approaches to the management of neuropathic pain: The role of topical analgesia. J Pain Symp Manag. 2007;33:356-364.
25. Attal N, Cruccu G, Baron R, etal. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010revision. Eur J Neurol. 2010;17:1113-e88.
26. Nayak S, Cunliffe M. Case report: Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases. Pediatr Anaesth. 2008;18(6):554-558.
27. Correa-IIlanes G, Calderon WO, Roa RG, Piñeros JB, Dote JA, Medina DG. Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster. Local and Regional Anesthesia. 2010;3:77-83.
28. Nicolaou A, Nicholson B, Hans G, Brasseur L. Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma. J Pain Research. 2011;4:25-38.
29. Wilhelm IR, Tzabazis A, Likar R, Sittl R, Griessinger N. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Eur J Anaesthesiol. 2010;27(2):169-173.